首页> 外文会议>International Congress on Coronary Artery Disease >Cardiovascular Risk in Diabetic Patients Determined by a Newly Developed Questionnaire on Autonomic Regulation (aR)
【24h】

Cardiovascular Risk in Diabetic Patients Determined by a Newly Developed Questionnaire on Autonomic Regulation (aR)

机译:糖尿病患者的心血管风险由新开发的自主法规问卷(AR)确定

获取原文

摘要

During the last years, the prevalence of type 2 diabetes has constantly been increasing and is becoming a political and economic challenge. Estimates of the prevalence of diabetes for the European and North American region range between 8 and 10 % (1). Among diabetes patients the prevalence of an associated significant coronary artery disease ranges between 65% and 75%. (2, 3).The estimated costs to cover diabetes care in 2025 will be between 7% and 13% of the world's healthcare budget (4). For the control of complications, regular screenings of the primarily affected organs play a crucial role (5). Cost-effective parameters for the determination of the necessary screening frequency are of great importance. A loss of regulation in patients with diabetes compared to healthy people and depending on diabetic complications could be shown with the "autonomic regulation" (aR), an 18 items questionnaire on autonomic regulation, containing three subscales: a) orthostatic-cir-culatory regulation, b) rest/activity regulation and c) digestive regulation (6, 7). In the present study, the coherence of the aR with the established prognostic markers heart rate variability (HRV) and heart rate (HR) is being examined,
机译:在过去几年中,2型糖尿病的患病率不断增加,正在成为一个政治和经济挑战。欧洲和北美地区糖尿病患病率估计为8至10%(1)。在糖尿病患者中,相关的显着冠状动脉疾病的患病率为65%和75%。 (2,3)。2025年覆盖糖尿病护理的估计成本将在世界医疗保健预算的7%至13%之间(4)。为了控制并发症,主要受影响的器官的定期放映起到至关重要的作用(5)。用于确定必要的筛选频率的经济有效参数非常重要。与健康人类相比,糖尿病患者和根据糖尿病并发症的患者的调节丧失可以通过“自主调节”(AR),18件关于自主法规调查问卷,其中包含三个分量:a)原疏图 - Cir-pulatory调节,b)静止/活动调节和c)消化法规(6,7)。在本研究中,正在检查与已建立的预后标志物心率变异性(HRV)和心率(HR)的相干性,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号